Nafamostat Reduces the Incidence of post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Clin Pharmacol Ther
; 115(2): 206-212, 2024 02.
Article
in En
| MEDLINE
| ID: mdl-38032816
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatitis
/
Benzamidines
/
Cholangiopancreatography, Endoscopic Retrograde
/
Guanidines
Type of study:
Systematic_reviews
Limits:
Adult
/
Humans
Language:
En
Journal:
Clin Pharmacol Ther
Year:
2024
Document type:
Article
Affiliation country: